SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (1050)10/6/2000 12:29:28 AM
From: Sharck  Read Replies (1) | Respond to of 1321
 
Haven't back read previous posts yet so sorry if this information is redundant. Certain US analysts yesterday suggested % of persons affected by QLTI utilizing light-activated drugs decreased from 24% to 17% of those carrying the disease. This is not the first time QLTIs revenue base has come into question. Appreciate any further discussion in this regards.



To: Ian@SI who wrote (1050)10/6/2000 2:30:11 AM
From: Edward W. Richmond  Respond to of 1321
 
Ian, as a long term holder of this stock, I fully agree with your assessment of the potential stock price appreciation. QLT is a company that will now begin to see the real returns from the years of R&D and quality partnerships.
I guess it's an ill wind that blows no good. Our family certainly took advantage of yesterday's price drop and did some buying in two accounts. We just couldn't turn down the bargain.:-):-)
Regards,
Ed


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News